Tuesday 7th February 2017
|Text too small?|
Trustees Executors, the trust company owned by Sterling Grace Corp, reached an agreement to pay about $4.9 million following an Inland Revenue Department audit of its 2013 tax year and the treatment of a $24 million legal settlement, its accounts show.
The firm hasn't disclosed the source of the settlement, which it recorded as other income in the year ended Sept. 30, 2013. That same year it paid $25.6 million, or $7.97 a share in dividends, more than five times more than its 2012 payment of $4.6 million, or $1.44 a share. The tax debt was treated as a contingent liability in its 2015 year.
Trustees Executors paid tax of $2.6 million in 2013 on profit of $33.6 million, a tax rate of just 7.7 percent. In its 2016 year it paid tax of $8.4 million on profit of $12.5 million, including the $4.9 million for 2013.
The firm has had numerous court battles since Sterling Grace acquired what was then known as Tower Trust in 2003, including actions against Perpetual Trust, Fund Managers Canterbury and the Official Assignee. The business was a listed company on the New Zealand stock exchange before being acquired by National Insurance Company in 1970. It became a subsidiary of Tower Corp in 1988 and was renamed Tower Trust New Zealand in April 1999 after Tower was demutualised.
Revenue in its latest year rose 5.2 percent to $38.4 million, of which the bulk was commission and fees.
No comments yet
Why I am backing Tony Falkenstein for the NZX Board - by Brent King
MARKET CLOSE: NZ shares fall; Contact, Trustpower give up gains
NZ dollar steady, markets looking ahead to next week's US data
Restaurant Brands sales to exceed $700 mln in 2018 as KFC market keeps growing, CEO says
NZ construction sector upbeat on infrastructure work, buoyed by govt injection
Vector signs multi-million battery storage deal with Territory Generation in Alice Springs
NZ wool prices fall; crossbred fleece hits lowest level in 7 1/2 years
Restaurant Brands to seek ASX dual-listing
NZ dollar rises after RBNZ maintains stance in latest rates review
While you were sleeping: Health care stocks rise